27.01.2022 - The Companies Plan to Jointly Submit a Psilocybin Clinical Trial Application to Health CanadaVANCOUVER, British Columbia, Jan. 27, 2022 (GLOBE NEWSWIRE) - KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) . Seite 1
VANCOUVER, British Columbia, Jan. 24, 2022 KetamineOne Capital Limited , an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital. | January 24, 2022
MIL-OSI: Ketamine One Begins Trading on the OTCQB Marketplace on January 12, 2022 foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.
MIL-OSI: Ketamine One Appoints Two New Members to Its Medical Advisory Board foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.